Acarbose
ApprovedCompleted 0 watching 0 views this week๐ฅ Hot
82
Development Stage
โ
Pre-clinicalโ
Phase 1โ
Phase 2โ
Phase 35
ApprovedIndication / Disease
Diabetes Mellitus Type 2
Conditions
Diabetes Mellitus Type 2
Trial Timeline
Jan 1, 2004 โ โ
NCT ID
NCT01244971About Acarbose
Acarbose is a approved stage product being developed by Bayer for Diabetes Mellitus Type 2. The current trial status is completed. This product is registered under clinical trial identifier NCT01244971. Target conditions include Diabetes Mellitus Type 2.
Hype Score Breakdown
Clinical
30
Activity
20
Company
7
Novelty
10
Community
12
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01244971 | Approved | Completed |
Competing Products
20 competing products in Diabetes Mellitus Type 2